A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma
The purpose of the study is to determine if the drug motexafin gadolinium will be an effective treatment for patients who have relapsed or refractory multiple myeloma.
Multiple Myeloma
DRUG: Motexafin Gadolinium Injection
Rate of complete response, partial response and stable disease (clinical benefit rate)
Progression-free survival|Safety and tolerability
The purpose of the study is to determine if the drug motexafin gadolinium will be an effective treatment for patients who have relapsed or refractory multiple myeloma.